Cardlytics Free Cash Flow (FCF) History (CDLX)

Cardlytics reported $8.8M in free cash flow for fiscal 2025, an increase of $19.2M from the previous fiscal year, with a free cash flow margin of 4.15%.

View full Cardlytics company overview

Cardlytics free cash flow by year

Cardlytics annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31$8.8M$19.2M+4.15%
20242024-12-31−$10.4M−$9.5M−4.06%
20232023-12-31−$852,000$54.2M−0.30%
20222022-12-31−$55.1M−$13.4M−19.87%
20212021-12-31−$41.6M−$28.6M−16.09%
20202020-12-31−$13.0M−$16.2M−6.96%
20192019-12-31$3.2M$28.1M+1.51%
20182018-12-31−$24.9M−$1.6M−16.53%
20172017-12-31−$23.3M$11.0M−17.89%
20162016-12-31−$34.3M−30.42%

Cardlytics free cash flow growth trends

Over the last five reported fiscal years, free cash flow grew from −$13.0M to $8.8M, a net increase of $21.8M. Cardlytics's latest reported quarter, Q2 2026, generated −$8.6M in free cash flow, a decrease of $9.5M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Cardlytics filings at SEC.gov ↗